Soluble CD95 (Fas/APO-1) in Malignant Glioma: (No) Implications for CD95-based Immunotherapy?

被引：0
作者：
Johannes R. Streffer
Monika Schuster
Frauke Zipp
Michael Weller
机构：
[1] University of Tübingen,Laboratory of Molecular Neuro
[2] School of Medicine,Oncology, Department of Neurology
来源：
Journal of Neuro-Oncology | 1998年 / 40卷
关键词：
CD95; glioma; apoptosis; CSF; brain;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
CD95 targeting is a novel approach of immunotherapy for malignant glioma that might be antagonized by the release of soluble CD95 by the tumor cells. An alternatively spliced CD95 mRNA that encodes a secreted CD95 variant has been detected in glioma cell lines in vitro and in human tumors in vivo. Here, we report that the levels of soluble CD95 in the serum of malignant glioma patients do not differ from those of lumbar disk disease patients. Soluble CD95 was detected in the CSF in 2 of 20 malignant glioma patients by ELISA. Bioassay studies indicate that these low levels of soluble CD95 in the CSF of some patients with malignant glioma cells are unlikely to interfere with CD95-based immunotherapy of malignant gliomas in vivo.
引用
收藏
页码：233 / 235
页数：2
相关论文
共 101 条
[1]  
Ogasawara J(1993)Lethal effect of the anti-Fas antibody in mice Nature 364 806-809
[2]  
Watanabe-Fukunaga R(1998)CD95 ligand: lethal weapon against malignant glioma? Brain Pathol 8 285-293
[3]  
Adachi M(1998)Fas expression on human fetal astrocytes without susceptibility to Fas-mediated cytotoxicity Neuroscience 84 627-634
[4]  
Matsuzawa A(1993)Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor superfamily, in normal and neoplastic cells Lab Invest 69 415-429
[5]  
Kasugai T(1994)Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule Science 263 1759-1762
[6]  
Kitamura Y(1998)Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing remitting multiple sclerosis Ann Neurol 43 116-120
[7]  
Itoh N(1998)Serum CD95 of multiple sclerosis patients protects from CD95-mediated apoptosis J Neuroimmunol 86 151-154
[8]  
Suda T(1995)Solublc Fas/APO-1 in tumor cells: a potential regulator of apoptosis? Cancer Lett 94 1-8
[9]  
Nagata S(1996)Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy Cancer Res 56 3870-3874
[10]  
Weller M(1995)Fas/APO-1 gene transfer for human malignant glioma Cancer Res 55 2936-2944
12345678910